Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of β-blockers

R Preston Mason, R Kubant, RF Jacob… - American journal of …, 2009 - academic.oup.com
Background Endothelial cell (EC) dysfunction contributes to hypertension and mechanisms
of atherosclerosis. Agents that improve EC function may provide vascular protection …
被引用次数：34 相关文章

[引用][C] Loss of Arterial and Renal Nitric Oxide Bioavailability in Hypertensive Rats With Diabetes: Effect of-Blockers

RP Mason, R Kubant, RF Jacob, P Malinski… - American Journal of …, 2009 - cir.nii.ac.jp

[引用][C] Loss of Arterial and Renal Nitric Oxide Bioavailability in Hypertensive Rats With Diabetes: Effect of β-Blockers

RP MASON, R KUBANT, RF JACOB… - American journal of …, 2009 - pascal-francis.inist.fr
Loss of Arterial and Renal Nitric Oxide Bioavailability in Hypertensive Rats With Diabetes:
Effect of β-Blockers CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers

RP Mason, R Kubant, RF Jacob… - American journal …, 2009 - pubmed.ncbi.nlm.nih.gov
Background Endothelial cell (EC) dysfunction contributes to hypertension and mechanisms
of atherosclerosis. Agents that improve EC function may provide vascular protection …

Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers

RP Mason, R Kubant, RF Jacob, P Malinski… - American Journal of …, 2009 - swepub.kb.se
BACKGROUND: Endothelial cell (EC) dysfunction contributes to hypertension and
mechanisms of atherosclerosis. Agents that improve EC function may provide vascular …
[PDF] researchgate.net

[PDF][PDF] Loss of Arterial and Renal Nitric Oxide Bioavailability in Hypertensive Rats With Diabetes: Effect of β-Blockers

RP Mason, R Kubant, RF Jacob… - AMERICAN …, 2009 - researchgate.net
Background Endothelial cell (EC) dysfunction contributes to hypertension and mechanisms
of atherosclerosis. Agents that improve EC function may provide vascular protection …

Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers

RP Mason, R Kubant, RF Jacob, P Malinski… - American Journal of …, 2009 - diva-portal.org
BACKGROUND: Endothelial cell (EC) dysfunction contributes to hypertension and
mechanisms of atherosclerosis. Agents that improve EC function may provide vascular …

Loss of Arterial and Renal Nitric Oxide Bioavailability in Hypertensive Rats With Diabetes: Effect of [beta]-Blockers

RP Mason, R Kubant, RF Jacob… - American Journal of …, 2009 - search.proquest.com
BackgroundEndothelial cell (EC) dysfunction contributes to hypertension and mechanisms
of atherosclerosis. Agents that improve EC function may provide vascular protection …

Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers.

RP Mason, R Kubant, RF Jacob, P Malinski… - American Journal of …, 2009 - europepmc.org
Background Endothelial cell (EC) dysfunction contributes to hypertension and mechanisms
of atherosclerosis. Agents that improve EC function may provide vascular protection …

Loss of Arterial and Renal Nitric Oxide Bioavailability in Hypertensive Rats With Diabetes: Effect of β-Blockers.

R Preston Mason, R Kubant, RF Jacob… - American Journal of …, 2009 - search.ebscohost.com
BackgroundEndothelial cell (EC) dysfunction contributes to hypertension and mechanisms
of atherosclerosis. Agents that improve EC function may provide vascular protection …